Market Overview:
The global injected facial aesthetic product market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The increasing demand for minimally invasive procedures, rising awareness about the benefits of facial aesthetics, and technological advancements are some of the major factors driving the growth of this market. The global injected facial aesthetic product market is segmented on the basis of type into dermal fillers and Botox. The dermal filler segment is expected to account for a larger share in terms of revenue in 2018, owing to its high adoption rates across various applications such as hospitals, aesthetic clinics, and others. However, Botox is projected to grow at a higher CAGR during the forecast period due to its growing popularity among consumers for reducing wrinkles and other signs of aging.
Product Definition:
An injected facial aesthetic product is a substance that is injected into the skin in order to improve its appearance. This product can be used to reduce the appearance of wrinkles, fill in scars, and improve the overall tone and texture of the skin. Injected facial aesthetic products are an important tool for improving the appearance of the face and can help people feel more confident about their appearance.
Dermal Fillers:
According to the American Society for Aesthetic Plastic Surgery, dermal fillers are one of the top 5 non-invasive procedures performed in the U.S. The society further stated that there were nearly 8 million aesthetic procedures performed in 2016 and this number is expected to increase over the forecast period thus indicating a significant growth potential for injected facial aesthetic products market globally.
Botox:
Botox is a brand name for a group of injectable drugs that reduce wrinkles. It was developed by Allergan and is marketed as a wrinkle reduction product. The FDA approved it as an anti-wrinkle treatment in 2011 and 2012, which was later on approved for facial lines in 2014 and 2015.
Application Insights:
Based on application, the global market is segmented into hospitals and aesthetic clinics. Hospitals held the largest share of around 60% in 2017 owing to their usage for treating patients with severe wrinkles or folds from head to toe. These are caused due to aging, stress, and lack of sleep among others. Botox is used most often in hospital settings as it provides faster results when compared to dermal fillers.
Aesthetic clinics are anticipated witness lucrative growth over the forecast period due its growing preference among women above 40 years old for improving their appearance through plastic surgery procedures such as facelifts & liposuction which involves injection of facial injectable products like filler & botulinum toxin (Botox). This trend has led these beauty salons/spa centers into becoming popular amongst female consumers globally who prefer a non-invasive treatment method that does not require any stitches after completion of procedure.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities, rising demand for cosmetic products, and growing awareness about aesthetic treatments among people of North America. In addition, presence of well-established healthcare facilities and availability of skilled professionals are also responsible for regional growth.
Asia Pacific is anticipated to witness fastest growth over the forecast period owing to rising disposable income levels in emerging countries such as China and India coupled with improving economic conditions in these countries which has led to an increase in medical tourism especially for aesthetic procedures such as face lift or Botox injections which will drive the market during the forecast period from 2018 To 2030 ( Exhibit 1).
Growth Factors:
- Increasing demand for minimally invasive procedures: The global Injected Facial Aesthetic Product market is witnessing a shift towards minimally invasive procedures, which is propelling the growth of the market. Minimally invasive procedures are less risky and cause minimal pain and discomfort to patients. This is encouraging more people to opt for these treatments, thereby driving the growth of the Injected Facial Aesthetic Product market.
- Growing popularity of non-surgical treatments: The popularity of non-surgical treatments is another key factor fuelling the growth of the Injected Facial Aesthetic Product market. Non-surgical treatments are less expensive and cause minimal pain and downtime compared to surgical procedures. They are also becoming increasingly popular among people who want to achieve a youthful appearance without going through surgery. This is boosting demand for Injected Facial Aesthetic Products, thereby driving market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Injected Facial Aesthetic Product Market Research Report
By Type
Dermal Fillers, Botox
By Application
Hospitals, Aesthetic Clinics
By Companies
Allergan, Ipsen, LIBP, US World Meds, Merz, Medytox, Hugel, Daewoong, Galderma, Bohus BioTech, Sinclair Pharma, IMEIK, Luminera, Suneva Medical, Teoxane
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Injected Facial Aesthetic Product Market Report Segments:
The global Injected Facial Aesthetic Product market is segmented on the basis of:
Types
Dermal Fillers, Botox
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Aesthetic Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Ipsen
- LIBP
- US World Meds
- Merz
- Medytox
- Hugel
- Daewoong
- Galderma
- Bohus BioTech
- Sinclair Pharma
- IMEIK
- Luminera
- Suneva Medical
- Teoxane
Highlights of The Injected Facial Aesthetic Product Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dermal Fillers
- Botox
- By Application:
- Hospitals
- Aesthetic Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Injected Facial Aesthetic Product Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Injected facial aesthetic products are a type of injectable that are used to improve the appearance of the face. These products are typically made from hyaluronic acid, which is a type of molecule that helps keep skin hydrated. Injected facial aesthetic products can be used to treat various issues with the face, such as wrinkles, age spots, and acne scars.
Some of the major companies in the injected facial aesthetic product market are Allergan, Ipsen, LIBP, US World Meds, Merz, Medytox, Hugel, Daewoong, Galderma, Bohus BioTech, Sinclair Pharma, IMEIK, Luminera, Suneva Medical, Teoxane.
The injected facial aesthetic product market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Injected Facial Aesthetic Product Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Injected Facial Aesthetic Product Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Injected Facial Aesthetic Product Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Injected Facial Aesthetic Product Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Injected Facial Aesthetic Product Market Size & Forecast, 2018-2028
4.5.1 Injected Facial Aesthetic Product Market Size and Y-o-Y Growth
4.5.2 Injected Facial Aesthetic Product Market Absolute $ Opportunity
Chapter 5 Global Injected Facial Aesthetic Product Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Injected Facial Aesthetic Product Market Size Forecast by Type
5.2.1 Dermal Fillers
5.2.2 Botox
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Injected Facial Aesthetic Product Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Injected Facial Aesthetic Product Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Aesthetic Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Injected Facial Aesthetic Product Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Injected Facial Aesthetic Product Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Injected Facial Aesthetic Product Analysis and Forecast
9.1 Introduction
9.2 North America Injected Facial Aesthetic Product Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Injected Facial Aesthetic Product Market Size Forecast by Type
9.6.1 Dermal Fillers
9.6.2 Botox
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Injected Facial Aesthetic Product Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Aesthetic Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Injected Facial Aesthetic Product Analysis and Forecast
10.1 Introduction
10.2 Europe Injected Facial Aesthetic Product Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Injected Facial Aesthetic Product Market Size Forecast by Type
10.6.1 Dermal Fillers
10.6.2 Botox
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Injected Facial Aesthetic Product Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Aesthetic Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Injected Facial Aesthetic Product Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Injected Facial Aesthetic Product Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Injected Facial Aesthetic Product Market Size Forecast by Type
11.6.1 Dermal Fillers
11.6.2 Botox
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Injected Facial Aesthetic Product Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Aesthetic Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Injected Facial Aesthetic Product Analysis and Forecast
12.1 Introduction
12.2 Latin America Injected Facial Aesthetic Product Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Injected Facial Aesthetic Product Market Size Forecast by Type
12.6.1 Dermal Fillers
12.6.2 Botox
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Injected Facial Aesthetic Product Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Aesthetic Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Injected Facial Aesthetic Product Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Injected Facial Aesthetic Product Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Injected Facial Aesthetic Product Market Size Forecast by Type
13.6.1 Dermal Fillers
13.6.2 Botox
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Injected Facial Aesthetic Product Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Aesthetic Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Injected Facial Aesthetic Product Market: Competitive Dashboard
14.2 Global Injected Facial Aesthetic Product Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Ipsen
14.3.3 LIBP
14.3.4 US World Meds
14.3.5 Merz
14.3.6 Medytox
14.3.7 Hugel
14.3.8 Daewoong
14.3.9 Galderma
14.3.10 Bohus BioTech
14.3.11 Sinclair Pharma
14.3.12 IMEIK
14.3.13 Luminera
14.3.14 Suneva Medical
14.3.15 Teoxane
